| 000 | 01649 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515204311.0 | ||
| 264 | 0 | _c20100316 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a0004-4172 | ||
| 024 | 7 |
_a10.1055/s-0031-1296454 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeng, Tao | |
| 245 | 0 | 0 |
_aA comparative study of the renoprotective effects of benidipine and valsartan in primary hypertensive patients with proteinuria. _h[electronic resource] |
| 260 |
_bArzneimittel-Forschung _c2009 |
||
| 300 |
_a647-50 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
| 650 | 0 | 4 |
_aDihydropyridines _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 |
_aKidney Diseases _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProteinuria _xcomplications |
| 650 | 0 | 4 |
_aRenal Circulation _xdrug effects |
| 650 | 0 | 4 |
_aTetrazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aValine _xanalogs & derivatives |
| 650 | 0 | 4 | _aValsartan |
| 700 | 1 | _aHu, Zhao | |
| 700 | 1 | _aXia, Qing | |
| 700 | 1 | _aJiang, Bei | |
| 700 | 1 | _aLi, Xianhua | |
| 700 | 1 | _aYang, Xiangdong | |
| 773 | 0 |
_tArzneimittel-Forschung _gvol. 59 _gno. 12 _gp. 647-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0031-1296454 _zAvailable from publisher's website |
| 999 |
_c19483583 _d19483583 |
||